VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 134 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $144,255 | -73.5% | 21,890 | -23.5% | 0.04% | -76.3% |
Q2 2018 | $545,000 | +40.1% | 28,611 | +23.9% | 0.17% | +84.0% |
Q1 2018 | $389,000 | -44.1% | 23,095 | -40.6% | 0.09% | -52.3% |
Q3 2017 | $696,000 | +161.7% | 38,900 | +104.7% | 0.20% | +80.7% |
Q1 2017 | $266,000 | – | 19,000 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,715,000 | $19,345,000 | 7.65% |
Avoro Capital Advisors LLC | 2,124,593 | $23,965,000 | 6.23% |
Asymmetry Capital Management, L.P. | 118,707 | $1,339,000 | 2.98% |
ARMISTICE CAPITAL, LLC | 760,000 | $8,573,000 | 2.93% |
Consonance Capital Management LP | 1,436,796 | $16,207,000 | 2.28% |
Palo Alto Investors LP | 3,997,108 | $45,087,000 | 2.17% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,784,157 | $53,965,000 | 2.09% |
PURA VIDA INVESTMENTS, LLC | 247,500 | $2,792,000 | 1.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,943,267 | $21,920,000 | 1.06% |
SPHERA FUNDS MANAGEMENT LTD. | 513,390 | $5,791,000 | 0.74% |